Management of Prenatally Diagnosed Isolated Right Aortic Arch

NCT04029064 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2020-03-10

No results posted yet for this study

Summary

The existence of a right aortic arch integrates nosologically into the group of aortic vascular arch anomalies. In the majority of cases, a right aortic arch is associated with cono-truncal congenital heart diseases (CHD), such as tetralogy of Fallot, pulmonary atresia with ventricular septal defect, and truncus arteriosus. Sometimes, a right aortic arch can be isolated, with an incidence of 0.05% to 0.1 %. Therefore, an assessment of the anatomy is necessary because an isolated right aortic arch can be associated with an encircling aortic arch anomaly and may subsequently have a functional repercussion, creating a digestive obstacle (oesophageal compression) and/or a respiratory obstacle (tracheal compression).

Furthermore, indications for surgery in this type of abnormalities are not well-established.

The diagnosis of a vascular artery anomaly is currently mostly made prenatally, with increasing diagnostic accuracy. Indeed, the application of the "3VT view" (e.g. three vessels and tracheae view) in routine prenatal sonographic screening for CHD has contributed to a better identification of such anomalies.

Prenatal diagnosis of an isolated right aortic arch involves the identification of the following aspects: the existence of a left ductus arteriosus may relate to an increased risk of an encircling aortic arch anomaly at birth; the analysis of the different vessels of the aortic arch, which can be difficult because of the fetal circulation and the maternal-fetal conditions of the examination; and the absence of a thymus, which suggests the existence of a genetic anomaly, such as DiGeorge syndrome.

After birth, the evaluation of the functional repercussion of the anomaly remains complex. The incidence of secondary symptoms to encircling abnormalities is estimated at 25%, but varies according to the anomaly: it is very frequent in case of a double aortic arch, variable in case of a right aortic arch with left ductus arteriosus (from 9% to 47% in the literature), absent in case of right aortic arch with right ductus arteriosus. Postnatal echocardiography can only assess the existence of a right aortic arch and check ductus arteriosus closure. The complete anatomical diagnosis of a vascular artery anomaly can only be made by slice cardiac imaging (CT scan or MRI), but in practice these examinations are not routinely performed in the absence of neonatal symptoms.

The aim of this study is to evaluate the accuracy of prenatally diagnosed isolated right aortic arch in terms of anatomy and functional prognosis.

The secondary aims are :

* to specify the association of an isolated right aortic arch with a genetic anomaly,
* to define the role of CT scan in children prenatally diagnosed with right aortic arch, in terms of diagnosis, prognosis and follow-up,
* to evaluate the incidence of respiratory and digestive complications in the first year of life,
* to evaluate the indications for surgical management during the first year of life.

Conditions

  • Isolated Right Aortic Arch

Sponsors & Collaborators

  • Congeital heart disease explorations unit - UE3C Lowendal - Paris

    collaborator UNKNOWN
  • University Hospital, Rouen

    collaborator OTHER
  • Nantes University Hospital

    collaborator OTHER
  • University Hospital, Grenoble

    collaborator OTHER
  • University Hospital, Bordeaux

    collaborator OTHER
  • Clinique La louvère - Lille - France

    collaborator UNKNOWN
  • University Hospital, Tours

    collaborator OTHER
  • University Hospital, Caen

    collaborator OTHER
  • University Hospital, Toulouse

    collaborator OTHER
  • Hospices Civils de Lyon

    collaborator OTHER
  • University Hospital, Marseille

    collaborator OTHER
  • Amiens University Hospital

    collaborator OTHER
  • Martinique University Hospital

    collaborator UNKNOWN
  • Centre Hospitalier Universitaire Dijon

    collaborator OTHER
  • Private cardiology practice, Massy

    collaborator UNKNOWN
  • Private cardiology practice, Marseille

    collaborator UNKNOWN
  • Private cardiology practice, Pontoise

    collaborator UNKNOWN
  • Private cardiology practice, Strasbourg

    collaborator UNKNOWN
  • Private cardiology practice, Brest

    collaborator UNKNOWN
  • Private cardiology practice, Rennes

    collaborator UNKNOWN
  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Sophie GUILLAUMONT, MD · University Hospital, Montpellier

Eligibility

Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-01
Primary Completion
2019-12-01
Completion
2019-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04029064 on ClinicalTrials.gov